Lansheng Biology's IPO on the Shenzhen Stock Exchange has been accepted. The process of several products such as isocamphor is filling the domestic gap.

According to the Securities Times app, on June 18th, Lansen Biotech Group Co., Ltd. (referred to as Lansen Biotech) has submitted its application for an IPO on the Shenzhen Stock Exchange. China CITIC Securities is its sponsoring institution, with a planned fundraising amount of 1.68625 billion yuan.